ASKP1240

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2014
012320122014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Blocking the CD40-CD154 interaction is reported to be effective for transplantation management and autoimmune disease models in… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
2014
2014
BACKGROUND Blocking the CD40-CD154 signal pathway has previously shown promise as a strategy to prevent allograft rejection. In… (More)
Is this relevant?
2014
2014
BACKGROUND The purpose of this study was to evaluate the serum concentration of ASKP1240 (pharmacokinetics [PK]) and the CD40… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
A strategy for inhibiting CD40 has been considered as an alternative approach for immunosuppression because of undesirable… (More)
Is this relevant?
2013
2013
This first-in-human, phase I study evaluated the safety, tolerability, pharmacokinetic and pharmacodynamic profile of ASKP1240 in… (More)
Is this relevant?
2013
2013
 
Is this relevant?
2012
2012
Blockade of the CD40-CD154 costimulatory signal is an attractive strategy for immunosuppression and tolerance induction in organ… (More)
  • figure 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2012
Review
2012
The goal of research in transplant therapeutics is to achieve safe and effective immunosuppression strategies that allow durable… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?